• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans
  • .org
  • Districts
  • Media
  • SupportUs
  • Collaborate
  • Contact
  • Search
  • Join


Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.


Photo

BioTime Inc.

Started by caliban , Mar 25 2011 01:11 AM
economics regenerative medicine stemells tissue engineering regmed

  • Please log in to reply
777 replies to this topic

#211 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 27 August 2012 - 06:53 PM

Consider These 3 Biotech Stocks For Potential Growth
Seeking Alpha - 1 hour ago
The biotech sector has been buzzing with activity lately, especially in the area of stem cell research for the treatment of cancer, tissue regeneration, and treatment of many other infections.

View the full article

#212 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 27 August 2012 - 12:47 PM

BioTime Obtains Expanded License to HyStem® Technology
MarketWatch (press release) - Aug 27, 2012
BioTime now holds exclusive worldwide license for all human medical applications of the core HyStem® technology -. ALAMEDA, Calif.

View the full article

#213 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 30 August 2012 - 09:01 PM

Geron to Present at the Stifel Nicolaus Healthcare Conference
Reuters (press release) - 51 minutes ago
MENLO PARK, Calif., August 30, 2012 - Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, will present an overview of the company at 10:55 a.m.

View the full article

sponsored ad

  • Advert

#214 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 31 August 2012 - 06:36 PM

Geron Corporation (NASDAQ:GERN ) Extends Rally On Analyst Note
Cogo - 16 minutes ago
Shares of Geron Corporation (NASDAQ:GERN) climbed another 2.50% percent to $2.69 on Friday after analysts at Stifel Nicolaus initiated coverage of the biotech group with a buy rating and a price target of $4.
PropThink: Geron Strong After Buy Rating but Investors Look for News on ... - Reuters
UPDATE: Stifel Nicolaus Initiates Geron Corporation at Buy with $4 PT ... - Benzinga

View the full article

#215 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 31 August 2012 - 08:05 PM

2-Star Stocks Poised to Plunge: Geron?
DailyFinance - 2 hours ago
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biopharmaceutical company Geron (NAS: GERN) has received a distressing two-star ranking.

View the full article

#216 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 01 September 2012 - 04:44 PM

Whoa! These Stocks Just Took Off!
DailyFinance - 2 hours ago
Oh, here's a shock: There are still financial troubles in Europe and Spain rattled the cage by delaying a decision on whether it will take a bailout from the EU.

View the full article

#217 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 04 September 2012 - 01:18 PM

Biotech Industry; Taiwan Will Leave Behind South Korea And Singapore ...
PT News - 43 minutes ago
Researchers covering the biotechnology industry say the agriculture sector in New Zealand is required to adopt genetically modified technology or run the risk of being left behind.

View the full article

#218 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 04 September 2012 - 07:14 PM

Healthcare Review: StemCells, Peregrine Pharmaceuticals, Achillion Jump ...
Proactive Investors USA & Canada - 1 hour ago
U.S. stocks came off session high on Friday after Federal Reserve Chairman Ben Bernanke maintained that the central bank could purchase more bonds to bolster the economy.

View the full article

#219 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 10 September 2012 - 04:38 PM

The Nasdaq Now: Tech Stocks Dragging Index Down
Minyanville.com - 23 minutes ago
MINYANVILLE ORIGINAL As investors wait to see whether Fed Chairman Ben Bernanke will announce more stimulatory measures at the FOMC meeting on Thursday, US stocks have stayed more or less flat, although poor performances by tech stocks ...

View the full article

#220 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 10 September 2012 - 07:15 PM

Nasdaq Stocks Heading Lower Today: GERN, ZLCS, TITN, SPRD, NIHD, MLNX
Active Investor - 1 hour ago
Nasdaq Geron Corporation (NASDAQ:GERN) is down 55.86% today at $1.28. GERN is down on extremely heavy volume today with 16.7 million shares traded.
Unusual 11 Mid-Day Movers 09/10: (GSI) (KSW) (BCOM) Higher; (GERN) (NDZ ... - StreetInsider.com (subscription)
Early Volume Leaders Below $5 (GERN, PPHM, AMD, ZLCS) - Expedated

View the full article

#221 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 19 September 2012 - 01:15 PM

BioTime CEO Michael D. West to Present at Stem Cells USA & Regenerative ...
DailyFinance - 1 hour ago
BioTime CEO Michael D. West to Present at Stem Cells USA & Regenerative Medicine Congress 2012. ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE MKT: BTX) announced that Chief Executive Officer Michael D. West, Ph.
BIOTIME, INC. : BioTime CEO Michael D. West to Present at Stem Cells USA ... - 4-traders

View the full article

#222 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 29 September 2012 - 01:17 AM

BioTime Forms BioTime Acquisition Corporation
EON: Enhanced Online News (press release) - Sep 29, 2012
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), an Alameda-based company engaged in research and development of innovative new products in the field of regenerative medicine utilizing stem cells and related technology, ...

View the full article

#223 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 18 October 2012 - 01:15 PM

BIOTIME, INC. : Issues Open Letter to Shareholders of Geron Corporation
4-traders - 3 hours ago
BioTime, Inc. : Issues Open Letter to Shareholders of Geron Corporation. 10/18/2012| 09:15am US/Eastern. BioTime, Inc. (NYSE MKT: BTX) today issued the following letter to the shareholders of Geron Corporation (Nasdaq: GERN) regarding Geron's stem ...
BioTime offers equity stake for Geron assets - MarketWatch
Geron's Last Chance - Seeking Alpha

View the full article

#224 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 18 October 2012 - 07:08 PM

BioTime (NYSE MKT: BTX) proposes stem cell assets acquisition deal – Issues ...
Proactive Investors USA & Canada - Oct 18, 2012
AN OPEN LETTER TO GERON SHAREHOLDERS. During 11/11, Geron (GERN) announced that it was discontinuing its stem cell research and development programs and its cliniCAl trials of OPC-1, a groundbreaking product to treat spinal cord injuries ...

View the full article

#225 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 18 October 2012 - 01:46 PM

BioTime offers equity stake for Geron assets
MarketWatch - Oct 18, 2012
By Saabira Chaudhuri. In an open letter, BioTime Inc. (ASE:BTX) urged Geron Corp. (NASDAQ:GERN) shareholders to push Geron's board to sell the company's stem cell assets to BioTime.

View the full article

#226 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 31 October 2012 - 01:31 PM

Geron Posts Narrower Loss - Analyst Blog
NASDAQ - 2 hours ago
Geron Corporation ( GERN ) posted a net loss of 13 cents per share in the third quarter of 2012, narrower than the Zacks Consensus Estimate of a loss of 14 cents and the year-ago loss of 16 cents.

View the full article

#227 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 12 November 2012 - 02:56 PM

Hadasit Bio-Holdings Ltd. Portfolio Company Cell Cure Neurosciences Ltd ...
Sacramento Bee - Nov 12, 2012
Hadasit Bio-Holdings Ltd. Portfolio Company Cell Cure Neurosciences Ltd. Receives Additional Financing From BioTime Inc. BioTime to provide $3.5 million in stock to Cell Cure to fund clinical development of OpRegen® for the treatment of age-related ...

View the full article

#228 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 12 November 2012 - 02:09 PM

BIOTIME, INC. : Hadasit Bio-Holdings Ltd. Portfolio Company Cell Cure ...
4-traders - Nov 12, 2012
BioTime, Inc. : Hadasit Bio-Holdings Ltd. Portfolio Company Cell Cure Neurosciences Ltd. Receives Additional Financing From BioTime Inc. 11/12/2012| 09:05am US/Eastern.

View the full article

#229 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 04 December 2012 - 02:23 PM

BIOTIME, INC. : BioTime CEO Dr. Michael West Presents Product Development ...
4-traders - 4 hours ago
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, announced that Chief Executive Officer Michael D. West, Ph.

View the full article

#230 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 18 December 2012 - 02:13 PM

BIOTIME, INC. : BioTime Reports Isolation of Seven Diverse Cartilage and Bone ...
4-traders - 8 hours ago
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, and its subsidiaries OrthoCyte Corporation and LifeMap Sciences reported today a means of manufacturing seven distinct ...

View the full article

#231 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 20 December 2012 - 02:15 PM

BIOTIME, INC. : BioTime Announces the Appointment of Jeffrey Janus as Vice ...
4-traders - 2 hours ago
BioTime, Inc. (NYSE MKT: BTX) today announced the appointment of Jeffrey Janus as its Vice President of Sales and Marketing.

View the full article

#232 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 07 January 2013 - 12:36 PM

BIOTIME, INC. : BioTime Signs Definitive Agreement With Geron Regarding ...
4-traders - 2 hours ago
BioTime, Inc. (NYSE MKT: BTX) and its recently formed subsidiary BioTime Acquisition Corporation (BAC) jointly announced today that they have entered into a definitive Asset Contribution Agreement with Geron Corporation (Nasdaq: GERN) to acquire the ...
Geron (GERN) To Sell Stem Cell Assets To Biotime (BTX) Subsidiary - iStockAnalyst
Geron to Divest Stem Cell Assets - MarketWatch (press release)

View the full article

#233 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 07 January 2013 - 12:30 PM


View the full article

#234 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 09 January 2013 - 02:52 PM

LifeMap Sciences, a Subsidiary of BioTime, Inc., Announces the Release of ...
DailyFinance - 1 hour ago
ALAMEDA, Calif.--(BUSINESS WIRE)-- LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of MalaCards version 1.02 on January 7. The new release is available at www.

View the full article

#235 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 10 January 2013 - 02:08 PM

BIOTIME, INC. : BioTime Submits Protocol for Initiation of Human Clinical ...
4-traders - 2 hours ago
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced it has submitted a Clinical Investigation Protocol (CIP) to European regulatory authorities for approval to ...

View the full article

#236 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 10 January 2013 - 02:08 PM

BIOTIME, INC. : BioTime Submits Protocol for Initiation of Human Clinical ...
4-traders - Jan 10, 2013
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced it has submitted a Clinical Investigation Protocol (CIP) to European regulatory authorities for approval to ...

View the full article

#237 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 30 January 2013 - 02:09 PM

BIOTIME, INC. : LifeMap Sciences, a Subsidiary of BioTime, Announces ...
4-traders - 3 hours ago
LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the publication of a paper authored by a research group under the supervision of Prof.

View the full article

#238 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 31 January 2013 - 02:22 PM

BIOTIME, INC. : BioTime's Subsidiary OncoCyte Corporation Provides an Update ...
4-traders - 11 minutes ago
BioTime, Inc. (NYSE MKT: BTX) and BioTime's subsidiary OncoCyte Corporation provided an update on the progress of development of PanC-DxTM, a novel blood-based diagnostic test utilizing molecular markers discovered at BioTime and OncoCyte ...

View the full article

#239 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 31 January 2013 - 02:22 PM

BIOTIME, INC. : BioTime's Subsidiary OncoCyte Corporation Provides an Update ...
4-traders - Jan 31, 2013
BioTime, Inc. (NYSE MKT: BTX) and BioTime's subsidiary OncoCyte Corporation provided an update on the progress of development of PanC-DxTM, a novel blood-based diagnostic test utilizing molecular markers discovered at BioTime and OncoCyte ...

View the full article

#240 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 11 February 2013 - 02:10 PM

BIOTIME, INC. : LifeMap Sciences, a Subsidiary of BioTime, Reports Its ...
4-traders (press release) - 2 hours ago
LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT:BTX), announced today that according to Google Analytics, the Company's databases have attracted over two million unique visitors in the previous 12 months.

View the full article
Back to Ventures & Markets



Also tagged with one or more of these keywords: economics, regenerative medicine, stemells, tissue engineering, regmed

0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users

  1. LONGECITY
  2. → Round Table Discussion
  3. → Business
  4. → Ventures & Markets
  5. site rules